EGLN1 and melanoma: Although the effect of haplo-deficiency of Phd2 in melanocytes is relatively weaker than that exhibited when biallelic deletion of Phd2 occurs, it is still sufficient to cooperate with oncogenic BRAF to induce melanoma.